UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM 8-K/A


                                 CURRENT REPORT
   Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934


          Date of Report (Date of earliest reported): February 24, 2004



                               STRATABID.COM, INC.
               (Exact name of registrant as specified in charter)



        Delaware                      333-99101              98-0381367
  (State or other jurisdiction      (Commission             (IRS Employer
     of incorporation)               File Number)          Identification No.)



   North Part of Xinquia Road, Yang Ling Agricultural
   High-Tech Industries Demonstration Zone
   Yang Ling, People's Republic of China                            712100
      (Address of principal executive offices)                   (Zip Code)


     Registrant's telephone number, including area code: 011-86-29-87074957


Item 1.  Change of Control of Registrant

The Acquisition

     On February 11, 2004,  Stratabid.com,  Inc. (the "Company") entered into an
Agreement  and  Plan of  Merger  with  Bodisen  Acquisition  Corp.,  a  Delaware
corporation  wholly-owned by the Company ("Subsidiary"),  Bodisen International,
Inc.,  a Delaware  corporation  ("Bodisen")  and the  shareholders  of  Bodisen.
Bodisen has one  wholly-owned  subsidiary in Shaanxi,  China,  Yang Ling Bodisen
Biology Science and Technology  Development Company Limited ("Yang Ling"). Under
the terms of the  agreement,  Stratabid.com  acquired  100 percent of  Bodisen's
stock in exchange for the issuance by  Stratabid.com  of three million shares of
its  common  stock  to  the  holders  of  Bodisen.  The  new  shares  constitute
approximately  66  percent of the  outstanding  shares of  Stratabid.com,  which
intends to change its name to Bodisen  Biotech,  Inc. The  Agreement and Plan of
Merger was closed on February 24, 2004.

     Bodisen's  Chairman of the Board,  Ms.  Qiong Wang has been  appointed  the
Company's  Chief  Executive  Officer,  DingXiang Yang has been  appointed  Chief
Financial  Officer and Yongning  Zhang has been appointed  Secretary.  Ms. Qiong
Wang has been appointed director.

About Bodisen

     Bodisen  is  incorporated  under the laws of the state of  Delaware  and is
headquartered  in the Shaanxi  Province,  People's  Republic  of China.  Bodisen
engages  in the  business  of  manufacturing  and  marketing  a brand of organic
fertilizer to the five leading agricultural provinces of China. Bodisen produces
numerous proprietary product lines, from pesticides to crop specific fertilizer.
These products are then marketed and sold to farmers throughout the 17 provinces
of China.  Bodisen conducts research and development to further improve existing
products and develop new formulas and products.

Industry Overview

     The organic fertilizer business in China is still in its infancy.  Compared
with traditional chemical fertilizer,  organic fertilizer is composed of natural
nutritional elements that enhance soil quality to increase crop yields,  without
the chemical side effect of harming soil  fertility.  In relation to traditional
compound   chemical   fertilizer,   organic  compound   fertilizer   accelerates
reproduction of soil microbes to improve soil quality through the  decomposition
of organic material.  This soil microbe enhanced by organic fertilizer  improves
the soil's  retention  of  nitrogen.  Moreover,  this  application  can activate
dormant soil by increasing soil nitrites and moisture  content that otherwise is
not enhanced by  traditional  chemical  fertilizers.  This process  controls the
release of nutritional  elements that enhances the quality,  quantity and health
of crops. As a result of years of intensive farming, China's soil quality is low
compared to  international  standards;  therefore it has been widely  recognized
that  organic  fertilizer  can  be  more  effective  than  traditional  chemical
fertilizer in stabilizing and enhancing soil quality.  Based on these facts, and
the fact that organic fertilizer can be widely utilized,  the market for organic
fertilizer  is  rapidly  growing  and the use of organic  fertilizer  has become
popular throughout China.

Products

     Bodisen  maintains over 60 package  products,  which are broken down into 3
product line categories:

     1.   Organic  Compound  Fertilizer  has been  found in tests  conducted  by
          Bodisen  with  local  area  farmers  in  Shaanxi,  which  are  further
          described in the  "Marketing"  description  below,  to increase yields
          within one  planting  season in a variety of crops  including,  wheat,
          maize,  tobacco and various vegetable and fruit crops.

                                       2

          Plants  tend to easily  absorb  organic  fertilizer  without  the side
          affects  found in synthetic  chemical  fertilizer  products,  and this
          organic process strengthens photosynthesis, which improves the overall
          health of a plant in resisting drought and disease.  The International
          Organization  for  Standardization  or  ISO  has  qualified  Bodisen's
          organic compound fertilizer products.

     2.   Liquid  Fertilizer  is a series of  products  which can be  applied to
          grapes,  pears,  cucumbers,  potatoes,  watermelon,  apples,  oranges,
          asparagus,  garlic and  strawberries.  By applying  liquid  fertilizer
          during the early stages of a plants development, plants absorb the key
          elements  and   nutrients   of  the   fertilizer,   which   strengthen
          photosynthesis,  improving the overall  health of the plant and making
          it more resistant to disease. In addition, liquid fertilizer heightens
          the color and luster of fruits and vegetables and the overall  quality
          of the end product.

     3.   Pesticides  and  Insecticides.Bodisen's   pesticide  products  can  be
          applied to fruit  trees and  vegetable  crops and will help  eliminate
          harmful pests that reduce  overall crop yields.  A sample of the pests
          that bring harm to crops in China include, but are not limited to, the
          peach fruit fly, white aphid,  red aphid,  red mite,  cotton bollworm,
          maize mite, cabbage butterfly,  leaf acaroids,  pear mite, grain worm,
          wheat moth, and the millet fly.

     All  of  Bodisen's  products  are  mass-produced  and  distributed  to  the
wholesalers and  distribution  centers in the 17 provinces in which Bodisen does
business.  The organic compound fertilizer and liquid fertilizer are used mainly
in the first half of each year. The busy periods of the farmers from south China
and north China are  different,  so the seasonal  sales of the organic  compound
fertilizer  and liquid  fertilizer  vary.  With regards to  pesticide,  the busy
period for this  product is from April to August of each year.  Our  wholesalers
sell the products to the farmers directly.


Marketing


     All  three-product  lines of  Bodisen  are  sold  directly  to the  farming
community in rural areas or wholesalers through our distribution  network.  This
consists of 12 established  branches each  representing 5 sales team responsible
for an assigned territory.

     Since  Bodisen's  inception,  the  "Bodisen"  brand  has been  aggressively
marketed and  promoted,  through trade fairs,  conventions  and the print media.
Bodisen also promotes its product lines through  television and radio  adverting
in China. Since the end-user for Bodisen's products is the local farmer, Bodisen
utilizes  educational  seminars to promote products  directly to farmers.  These
educational  seminars are conducted  locally in China and explain the advantages
of organic fertilizers and how they may be used to enhance crop yields.  Bodisen
markets directly to farmers, which allows Bodisen to collect feedback to help in
preparing and designing products based on the needs of the farmers.  Included in
this process is the  distribution  of free samples  that attract  attention  and
increase brand awareness.

     The free samples are made  available to allow  farmers the  opportunity  to
test the product and compare it to other fertilizer products.  After the farmers
participate  in this  test,  Bodisen  announces  and  promotes  the  results  to
surrounding  towns in the test  zone.  The cost of this is not  material  and is
often  offset by new sales in that test zone.  The  objective of this test is to
compare Bodisen's products with the similar products of the competitors.


     The primary task for sales and marketing is to  strengthen  the home market
in Shaanxi  province and expand the market  outside  Shaanxi  province  into new
districts where Bodisen's products are not well established. Bodisen will try to
accomplish  this  through  traditional  means,  which  are  to  use  the  market
strategies  of  price  control  and  the   establishment   of  franchising   its
distribution to wholesalers.

                                       3

     Bodisen intends to increase  marketing in regions where Bodisen's  products
are not well known.  In addition,  Bodisen  will  promote its  products  through
national  newspapers in China  explaining the advantages of the high-tech nature
of its  environmental  or "green"  product lines. In order to enter the untapped
markets of western  China,  Bodisen will  explore  selling  exclusive  franchise
opportunities to new wholesale agents.

Sources and Availability of Raw Materials (Vendors)

     There are numerous  suppliers  and vendors of raw  materials in the Shaanxi
Province  of  China  from  which  Bodisen  can  choose  from in  satisfying  its
production  requirements.  We have no contracts  with trade  vendors and conduct
business on an order-by-order  basis, a practice that is typical  throughout the
industry  in  China.  We  believe  that we have  very  good  relations  with the
agricultural vendor community.

Customers

     All orders for  Bodisen's  products  are informal  and are  indications  of
interest  which can be canceled by the  customers at anytime and for any reason.
In China,  orders of indication are the norm, and are based on the goodwill of a
company's  relationships with its customers.  All orders that Bodisen signs with
customers  are informal  indications  of interest and no there are no written or
verbal sales  contracts with its  customers.  Signed orders on file with Bodisen
will  be  filled  on  a  first  come-first  served  basis,  as  the  product  is
manufactured and distributed.

Intellectual Property

     Bodisen  owns a  trademark  on the  "BODISEN"  name,  which  is used on all
Bodisen  products.  BODISEN is also a recognized  trade name in the provinces in
China in which Bodisen conducts business.


     Bodisen holds no patents and has not applied for patents on its proprietary
technology or formulas because Bodisen believes  application for such patents in
China would result in public  knowledge of Bodisen  proprietary  technology  and
formulas, which would be detrimental to its future well-being.  Only certain key
executives  of  Bodisen  have  knowledge  of  such  proprietary  technology  and
formulas.

Research and Development

     Bodisen's  research and  development  team consists of nine  professionals,
which  perform  administrative  and  ministerial  functions.  Much of  Bodisen's
research work is done in close  cooperation with  universities and research labs
in the Yang Ling and Xian metropolitan  areas and the cost of such research work
is incurred by such universities and research labs and not by Bodisen.

     In 2004, Bodisen plans to spend $130,000.00 on research and development,  a
majority of which is dedicated to current experiments to develop new products.

Current Research and Development Projects

     Project  Ion:  The  study of metal  ions,  copper,  zinc  and  maganese  in
combination  with silver positive ion to control and remove crop disease brought
about by fungus.  Bodisen is trying to  determine  if the  combination  of these
metal ions will  prohibit  the release of an  intrusive  enzyme from fungus that
kills crops in China.

                                       4

     Project Fly: The  development  of a protein  abstract  from a common fly to
develop  bacteria-based  pesticides,  which may have  better  effect on  plant's
resistance to insects.  This project seeks to isolate a series of  anti-bacteria
peptides from the proteins of a common fly. This kind of  anti-bacteria  peptide
could effectively control many pathogens which may prove better than pesticide's
currently available.

     Project  Amino Acid:  Program to build a new compound  fertilizer  product,
based on a proactive amino acid enzyme.


     Project  Build:  A  technique  for the  manufacturing  of organic  compound
fertilizer, which could enhance the quality of organic fertilizer products.

Governmental and Environmental Regulation

     Through  the laws and  regulation  of the  People's  Republic  of China and
Shaannxi Provincial  government,  Bodisen's products and services are subject to
material  regulation by governmental  agencies  responsible for the Agricultural
Industry and through the  government  district  where Bodisen is  headquartered.
Business and company registrations, along with Bodisen's products, are certified
on a regular basis and must in compliance  with the laws and  regulations of the
state  governments  and industry  agencies,  which are  controlled and monitored
through the issuance of licenses.  To date,  Bodisen has been compliant with all
registrations  and requirements for the issuance and maintenance of all licenses
required by the governing  bodies.  As of December 1, 2003, all license fees and
filings are current. These licenses include:


     o    PRODUCTION OF ORGANIC COMPOUND FERTILIZER  LICENSE.  Authorized by the
          Shaanxi  Soil  and  Fertilizer  Institution.  After  June  2004,  this
          production  license  will  be  transferred  to  a  Production  License
          authorized by Ministry of Agriculture, People's Republic of China.
     o    CERTIFICATE FOR PESTICIDE REGISTRATION. Is required for the production
          of liquid  fertilizer and issued by Ministry of Agriculture,  People's
          Republic of China.
     o    PRODUCTION  STANDARD.  Registered with Bureau of Quality  Controls and
          Technology, Shaanxi Provincial Government, Xi'an.

     There is no prohibitive  cost in obtaining and maintaining  these licenses,
as it is illegal to do business  without  these  licenses.  As it is an accepted
business  practice to operate within the regulations of the issued license,  the
issuance  of the  license  is  considered  acost  of  doing  business  and  fees
associated with this are minimal. If Bodisen were to lose any of these licenses,
it would only have a limited  time to reapply for such  licenses  and would face
possible regulatory fines. Bodisen is not subject to any environmental  controls
or restrictions  that require the outlay of capital or the obtaining of a permit
in order to engage in business operations.

Employees

     As of December 1, 2003, Bodisen employed a total of 349 employees, 251 on a
full-time basis, 26 of which are clerical,  74 of which are in operations,  5 in
accounting,  128 of which are sales and marketing, 9 of which are administrative
and 9 of which are research and  development.  Bodisen also employs 98 part-time
employees which are farmers.


                                       5


Competition

     The  compound   fertilizer   industry  is  largely   fragmented  with  most
competitors operating small regional factories, serving local requirements. Most
companies in this industry in China do not promote their products  through brand
name recognition.

     Bodisen has not yet  identified any  competition  in Shaanxi  province that
operates in all three segments  (compound,  liquid and pesticide) of the organic
fertilizer  business.   Bodisen's  nearest  competitor  is  Tian  Bang  Shaanxi.
Management believes that the only international company operating in China which
is a competitor to Bodisen is DuPont.  Bodisen competes and sells it products in
seventeen  provinces  throughout  China  including  Shaanxi,   Hebei,  Shandong,
Liaoning, Jilin, Heilongjiang, Gansu, Sichuan, Henan, Shanxi, Guangxi, Xinjiang,
Inner Mongolia, Ningxia, Qinghai, Yunnan and Hainan.

Description of Property

     Bodisen's  principal executive offices are located at North Part of Xinquia
Road, Yang Ling Agricultural High-Tech Industries  Demonstration Zone Yang Ling,
Shaanzi province, People's Republic of China, 712100 and our telephone number is
011-86-29-87074957.  Bodisen owns two factories, which includes three production
lines, an office building, one warehouse,  and two research labs and, is located
on 10,900  square  meters of land.  Bodisen also leases a warehouse in Yang Ling
near the site of Bodisen's  factories.  This  warehouse is 300 square  meters in
area.  The rent of the  warehouse  is $1,500.00 a month from May 20, 2003 to May
20, 2004.

EXECUTIVE OFFICERS

Qiong Wang, Chief Executive Officer

     Ms. Qiong Wang has served as the  Chairman of the Board of Directors  since
founding Yang Ling in September  2001.  From 1997 to May 2001,  Ms. Wang was the
Chief  Executive  Officer and President of Shaanxi  Bodison  Chemical Co., Ltd.,
which  became  Yang  Ling.  From May 1996 to  December  1997,  Ms.  Wang was the
President  of Yang Ling Kang Yuan  Chemical  Company.  Ms. Wang  graduated  from
North-West Agronomy College, with a Bachelor of Science degree in 1986.


Dingxiang Yang, Chief Financial Officer

     Mr. Yang is a Certified  Public  Accountant in China. Mr. Yang has been the
Chief Financial Officer of Bodisen since January 2004. From 1997 until 2003, Mr.
Yang was the Head of Accounting Department at ShaanXi Agricultural  Corporation,
a government  agricultural  product  distribution firm. Mr. Yang was the Head of
Accounting  Department of Xi'An Electric  Motor  Institute from 1986 until 1997.
Mr.  Yang  received  a  Bachelor's  degree in  accounting  from  ShaanXi  Second
Institute of Commerce in 1986.

Yongning Zhang, Secretary

     Mr. Zhang has been the human  resources  manager  since 1999. He received a
Bachelor's  degree in business  management  from  ShaanXi  Baoji Arts & Sciences
Institute in 1999.

                                       6

Executive Compensation

     The following table sets forth in summary form the compensation received by
our Chief  Executive  Officer and other officers  earning in excess of $100,000,
for the last three fiscal years of the Company.


                                                                                           long-term
Name                                  annual compensation                              compensation awards
and                                 ----------------------------                      ----------------------
principal                                            annual                           securities underlying
position                                    year     salary    bonus       other      options/sars
- ---------                                   ----     ------    -----      ---------   ----------------------
                                                                              
Derek Wasson                                2003       --       --       $32,694 (3)          ---
         Chief Executive Officer            2002       --       --       $19,047 (3)          ---
                                            2001(1)    --


Steven Bruk                                 2001(2)    --       --            --              ---
Chief Executive Officer

(1) For the period January 25, 2001 to December 31, 2001.
(2) For the period January 1, 2001 to January 25, 2001
(3) Represents consulting fees paid.

Related Party Transactions

         None.


Item 4.  Change in Registrant's Certifying Accountant

     On February 26,  2004,  the Company  notified  Manning  Elliott,  Chartered
Accountants ("Elliott"), its independent public accountant, that the Company was
terminating  his services,  effective as of that date.  The  Company's  Board of
Directors approved such decision.

     Elliott's opinion in his report on the Company's  financial  statements for
the years ended  December  30,  2001 and 2002  contained  no adverse  opinion or
disclaimer  of opinion  and was not  qualified  or modified as to audit scope or
accounting principle. During the two most recent fiscal years and the subsequent
interim period preceding February 26, 2004 (date of termination),  there were no
disagreements with Elliott on any matter of accounting  principles or practices,
financial  statement   disclosure,   or  auditing  scope  or  procedure,   which
disagreements, if not resolved to the satisfaction of Elliott, would have caused
disagreements in connection with his report on our financial  statements for any
such periods.

     On  February  26,  2004,  the  Company  engaged  Kabani  &  Company,   Inc.
("Kabani"),  as  its  independent  public  accountants.   The  Company  did  not
previously  consult with Kabani regarding any matter,  including but not limited
to:

     o    the application of accounting  principles to a specified  transaction,
          either completed or proposed;  or the type of audit opinion that might
          be rendered on the Company's financial statements; or


     o    any matter that was either the subject  matter of a  disagreement  (as
          defined  in Item  304(a)(1)(iv)  of  Regulation  S-B  and the  related
          instructions) or a reportable  event (as defined in Item  304(a)(1)(v)
          of Regulation S-B).

                                       7

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS


(a)  Financial Statements of businesses acquired.

     1. Audited Financial Statements of Bodisen, Inc.

     2. Pro-forma consolidated financial statements of the Company.

(b)  Exhibits.

     3. Agreement and Plan of Merger by and among Stratabid.com, Inc.,
        Bodisen Acquisition Corp., Bodisen, and the shareholders of
        Bodisen, made as of the 11th day of February, 2004. (Previously filed)

     4. Letter from Manning Elliott, Chartered Accountants, dated
        February 26, 2004. (Previously filed)

SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                           STRATABID.COM, INC.



Date:  June 29, 2004                        /s/Qiong Wang
                                            --------------
                                               Qiong Wang,
                                         Chief Executive Officer


                                       8

                          INDEPENDENT AUDITORS' REPORT






Board of Directors and Shareholders
Bodisen International, Inc.,

We have audited the accompanying consolidated balance sheets of Bodisen
International Inc, and subsidiary as of December 31, 2003 and 2002, and the
related consolidated statements of income, shareholders' equity, and cash flows
for the years ended December 31, 2003 and 2002. These consolidated financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these consolidated financial
statements based on our audits.

We conducted our audits in accordance with auditing standards generally accepted
in the United States of America. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of Bodisen
International Inc, and subsidiary as of December 31, 2003 and 2002, and the
consolidated results of their operations and cash flows for the years ended
December 31, 2003 and 2002 in conformity with accounting principles generally
accepted in the United States of America.





/s/ Kabani & Company, Inc.

CERTIFIED PUBLIC ACCOUNTANTS
Fountain Valley, California
February 5, 2004

                                       9

Exhibit 1
                   BODISEN INTERNATIONAL, INC. AND SUBSIDIARY
                           CONSOLIDATED BALANCE SHEETS
                           DECEMBER 31, 2003 AND 2002



                                     ASSETS

                                                                                      2003              2002
                                                                                ---------------    ---------------
                                                                                                    
 CURRENT ASSETS:
      Cash & cash equivalents                                                   $    2,974,773            233,182
      Accounts receivable, net                                                       1,822,841          2,071,927
      Advances to Suppliers                                                          1,933,516          1,662,872
      Inventory                                                                        715,732            797,270
                                                                                ---------------      -------------
                  Total current assets                                               7,446,862          4,765,250

 PROPERTY AND EQUIPMENT, net                                                         1,220,587          1,225,490

 CAPITAL WORK IN PROGRESS                                                              222,083            217,206

 INTANGIBLE ASSETS, net                                                              2,310,148            949,242

                                                                                ---------------    ---------------
                                                                                $   11,199,680     $    7,157,188
                                                                                ===============    ===============



                      LIABILITIES AND STOCKHOLDERS' EQUITY

 CURRENT LIABILITIES:
      Accounts payable                                                          $    1,634,163     $    1,098,978
      Accrued expenses                                                                  75,755                  -
      Unearned revenue                                                                  15,888            601,975
      Short term loan                                                                1,092,000             12,000
      Dividend payable                                                                       -            180,000
      Other payables                                                                    14,300             81,423
                                                                                ---------------    ---------------
                  Total current liabilities                                          2,832,106          1,974,375

 STOCKHOLDERS' EQUITY
      Common stock, $0.001 per share; authorized shares 50,000,000;
       issued and outstanding 1,500 shares                                                   1                  1
      Additional paid in capital                                                     6,014,399          4,799,999
      Statutory reserve                                                                263,795             66,758
      Retained earnings                                                              2,089,379            316,054
                                                                                ---------------    ---------------
                  Total stockholders' equity                                         8,367,574          5,182,813

                                                                                ---------------    ---------------
                                                                                $   11,199,680     $    7,157,188
                                                                                ===============    ===============

                                        10

                   BODISEN INTERNATIONAL, INC. AND SUBSIDIARY
                        CONSOLIDATED STATEMENTS OF INCOME
                 FOR THE YEARS ENDED DECEMBER 31, 2003 AND 2002



                                                                                       2003                2002
                                                                                ---------------    ---------------
                                                                                              
    Net revenue                                                                   $  9,783,784      $   4,881,350

    Cost of revenue                                                                  6,706,082          3,582,176
                                                                                ---------------    ---------------

    Gross profit                                                                     3,077,702          1,299,174

    Operating expenses
            Selling expenses                                                           573,807            235,077
            General and administrative expenses                                        630,401            384,067
                                                                                ---------------    ---------------
                  Total operating expenses                                           1,204,207            619,144
                                                                                ---------------    ---------------

    Income from operations                                                           1,873,495            680,030

    Non-operating Income (expense):
            Other income                                                                55,507              8,119
            Interest expense                                                            41,359            (20,565)
                                                                                ---------------    ---------------
                  Total non-operating income (expense)                                  96,867            (12,446)
                                                                                ---------------    ---------------

    Net income                                                                    $  1,970,361      $     667,583
                                                                                ===============    ===============

    Basic and diluted weighted average shares outstanding                                1,500              1,500
                                                                                ===============    ===============

    Basic and diluted net earning per share                                       $   1,313.57      $      445.06
                                                                                ===============    ===============


                                       11

                   BODISEN INTERNATIONAL, INC. AND SUBSIDIARY
                 CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
                 FOR THE YEARS ENDED DECEMBER 31, 2003 AND 2002



                                                     Common Stock          Additional                   Retained          Total
                                                 Number of                  Paid in       Statutory     Earnings       Stockholders'
                                                  shares       Amount       Capital        Reserve      (Deficit)        Equity
                                               ------------  -----------   -----------  ------------- ------------   ---------------
                                                                                                     
Balance, December 31, 2001                        1,500      $4,800,000    $        -    $         -   $ (104,771)    $   4,695,229

Recapitalization on reverse acquisition               -      (4,799,999)    4,799,999              -            -                 -
                                               ------------  -----------   -----------  ------------- ------------   ---------------

Balance after recapitalization                    1,500               1     4,799,999              -     (104,771)        4,695,229

Net income for the year ended December 31,
 2002                                                  -              -             -              -      667,583           667,583

Allocation to statutory reserve                        -              -             -         66,758      (66,758)                -

Dividends declared                                     -              -             -              -     (180,000)         (180,000)

                                               ------------  -----------   -----------  ------------- ------------   ---------------
Balance, December 31, 2002                         1,500              1     4,799,999         66,758      316,054         5,182,813

Issuance of subsidiary's stock                         -              -     1,214,400              -            -         1,214,400

Net income for the year ended December 31, 2003        -              -             -              -    1,970,361         1,970,361

Allocation to statutory reserve                        -              -             -        197,036     (197,036)                -

                                               ------------  -----------   -----------  ------------- ------------   ---------------
Balance, December 31, 2003                         1,500      $       1    $6,014,399      $ 263,794  $ 2,089,379    $    8,367,574
                                               ============  ===========   ===========  ============= ============   ===============

                                       12


                   BODISEN INTERNATIONAL, INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                 FOR THE YEARS ENDED DECEMBER 31, 2003 AND 2002


                                                                                     2003             2002
                                                                                  -----------      -----------
                                                                                             
CASH FLOWS FROM OPERATING ACTIVITIES:
        Net Income                                                                $1,970,361       $  667,583
        Adjustments to reconcile net income to net cash
        provided by operating activities:
                 Depreciation and amortization                                       247,958          149,699
                 (Increase) / decrease in current assets:
                         Accounts receivable                                         249,086          288,218
                         Advances to suppliers                                      (270,645)        (893,393)
                         Inventory                                                    81,538          300,312
                 Increase / (decrease) in current liabilities:
                         Accounts payable                                            535,186          (38,379)
                         Unearned revenue                                           (586,087)         589,812
                         Other payables                                              (67,122)           3,423
                         Accrued expenses                                             75,754         (130,252)
                                                                                  -----------      -----------
        Net cash provided by operating activities                                  2,236,028          937,023
                                                                                  -----------      -----------

CASH FLOWS FROM INVESTING ACTIVITIES
                 Acquisition of property & equipment                                (133,653)        (600,666)
                 Acquisition of rights to use land                                (1,470,307)               -
                 Capital work in process                                              (4,877)        (217,206)
                                                                                  -----------      -----------
        Net cash used in investing activities                                     (1,608,837)        (817,872)
                                                                                  -----------      -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
                 Payments on loan from officers/shareholders                               -         (217,338)
                 Proceeds from loan                                                1,080,000           12,000
                 Issuance of stock by subsidiary                                   1,214,400                -
                 Dividend paid                                                      (180,000)               -
                                                                                  -----------      -----------
         Net cash provided by (used in) financing activities                       2,114,400         (205,338)
                                                                                  -----------      -----------

NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS                                 2,741,591          (86,187)

CASH & CASH EQUIVALENTS, BEGINNING BALANCE                                           233,182          319,369
                                                                                  -----------      -----------

CASH & CASH EQUIVALENTS, ENDING BALANCE                                           $2,974,773       $  233,182
                                                                                  ===========      ===========

                                       13

                   BODISEN INTERNATIONAL, INC. AND SUBSIDIARY
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS



     1.   ORGANIZATION AND DESCRIPTION OF BUSINESS

     Bodisen  International,  Inc. (the  "Company")  is a Delaware  Corporation,
     incorporated  on November 19, 2003.  The Company is  authorized to issue of
     50,000,000  shares of common stock of $.001 par value and 10,000,000 shares
     of  preferred  stock of $.001 par value.  The  Company  is a  non-operative
     holding  company  of Yang  Ling  Bodisen  Biology  Science  and  Technology
     Development  Company  Limited  ("BBST").  BBST was founded in the  People's
     Republic  of  China  on  August  31,  2001.  BBST,  located  in  Yang  Ling
     Agricultural High-Tech Industries  Demonstration Zone, is primarily engaged
     in developing,  manufacturing  and selling  pesticides and compound organic
     fertilizers in the People's Republic of China.

     On December 15, 2003,  the Company  entered in to an agreement with all the
     shareholders  of BBST  to  exchange  all of the  outstanding  stock  of the
     Company  for all the  issued  and  outstanding  stock  of BBST.  After  the
     consummation  of the agreement,  the former  shareholders  of BBST own 1500
     shares  of  common  stock  of the  Company,  which  represent  100%  of the
     Company's  issued  and  outstanding  shares.  For U.S.  Federal  income tax
     purpose,  the  transaction  is  intended  to  be  qualified  as a  tax-free
     transaction  under  section 351 of the Internal  Revenue  Code of 1986,  as
     amended.

     The  exchange  of  shares  with  BBST has been  accounted  for as a reverse
     acquisition  under the purchase method of accounting since the shareholders
     of the BBST obtained control of the consolidated entity.  Accordingly,  the
     merger of the two  companies  has been  recorded as a  recapitalization  of
     BBST,  with BBST being treated as the  continuing  entity.  The  historical
     financial  statements  presented are those of BBST. The continuing  company
     has retained  December 31 as its fiscal year end. The financial  statements
     of the  legal  acquirer  are  not  significant;  therefore,  no  pro  forma
     financial information is submitted.

     2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     Use of Estimates

     The  preparation  of financial  statements  in  conformity  with  generally
     accepted  accounting  principles  requires management to make estimates and
     assumptions  that affect the reported amounts of assets and liabilities and
     disclosure  of  contingent  assets  and  liabilities  at  the  date  of the
     financial  statements  and the  reported  amounts of revenues  and expenses
     during  the  reporting  period.  Actual  results  could  differ  from those
     estimates.

     Principles of consolidation

     The accompanying  consolidated financial statements include the accounts of
     the  Company  and  its  wholly  owned  subsidiary,  BBST.  All  significant
     inter-company   accounts  and   transactions   have  been   eliminated   in
     consolidation.  The  acquisition  of BBST on December  15,  2003,  has been
     accounted for as a purchase and treated as a reverse  acquisition (note 1).
     The  historical  results for the year ended  December 31, 2003 include both
     the Company (from the acquisition  date) and BBST (for full year) while the
     historical results for the year ended December 31, 2002 includes only BBST.

     Cash and cash equivalents

     Cash and cash  equivalents  include cash in hand and cash in time deposits,
     certificates  of  deposit  and all  highly  liquid  debt  instruments  with
     original maturities of three months or less.

                                       14

     Accounts Receivable

     The Company  maintains  reserves for  potential  credit  losses on accounts
     receivable.  Management reviews the composition of accounts  receivable and
     analyzes  historical bad debts,  customer  concentrations,  customer credit
     worthiness,  current  economic  trends  and  changes  in  customer  payment
     patterns to evaluate the adequacy of these reserves.  Reserves are recorded
     primarily on a specific  identification basis. Allowance for doubtful debts
     amounted to $64,080 as at December 31, 2003 and 2002.

     Advances to suppliers

     The Company  advances to certain vendors for purchase of its material.  The
     advances to suppliers amounted to $1,933,516 and $1,662,872 at December 31,
     2003 and 2002.

     Inventories

     Inventories  are  valued at the  lower of cost  (determined  on a  weighted
     average basis) or market.  The Management  compares the cost of inventories
     with  the  market  value  and  allowance  is  made  for  writing  down  the
     inventories to there market value, if lower.

     Property & Equipment

     Property and equipment are stated at cost. Expenditures for maintenance and
     repairs  are  charged to  earnings as  incurred;  additions,  renewals  and
     betterments  are  capitalized.  When  property and equipment are retired or
     otherwise  disposed of, the related cost and accumulated  depreciation  are
     removed from the respective  accounts,  and any gain or loss is included in
     operations.  Depreciation  of property and equipment is provided  using the
     straight-line  method for substantially all assets with estimated lives of:
     30 years for building, 10 years for machinery, 5 years for office equipment
     and 8 years for vehicles.

     Long-lived assets

     Effective  January 1, 2002,  the Company  adopted  Statement  of  Financial
     Accounting Standards No. 144, "Accounting for the Impairment or Disposal of
     Long-Lived Assets" ("SFAS 144"), which addresses  financial  accounting and
     reporting  for  the  impairment  or  disposal  of  long-lived   assets  and
     supersedes  SFAS No. 121,  "Accounting  for the  Impairment  of  Long-Lived
     Assets and for Long-Lived Assets to be Disposed Of," and the accounting and
     reporting  provisions  of APB  Opinion  No. 30,  "Reporting  the Results of
     Operations  for  a  Disposal  of a  Segment  of a  Business."  The  Company
     periodically  evaluates the carrying value of long-lived  assets to be held
     and used in accordance with SFAS 144. SFAS 144 requires  impairment  losses
     to be recorded on long-lived  assets used in operations  when indicators of
     impairment  are present and the  undiscounted  cash flows  estimated  to be
     generated by those assets are less than the assets'  carrying  amounts.  In
     that event, a loss is recognized  based on the amount by which the carrying
     amount  exceeds the fair market  value of the  long-lived  assets.  Loss on
     long-lived  assets to be disposed  of is  determined  in a similar  manner,
     except that fair market values are reduced for the cost of disposal.  Based
     on its review, the Company believes that, as of December 31, 2003 and 2002,
     there were no significant impairments of its long-lived assets.

                                       15

     Intangible Assets

     Intangible assets consist of Rights to use land and Fertilizers proprietary
     technology rights. The Company evaluates  intangible assets for impairment,
     at least on an annual basis and whenever events or changes in circumstances
     indicate that the carrying value may not be recoverable  from its estimated
     future cash flows.  Recoverability of intangible  assets,  other long-lived
     assets and,  goodwill is measured by comparing  their net book value to the
     related projected undiscounted cash flows from these assets,  considering a
     number of factors  including  past  operating  results,  budgets,  economic
     projections,  market trends and product development cycles. If the net book
     value of the asset exceeds the related  undiscounted  cash flows, the asset
     is  considered  impaired,  and a second  test is  performed  to measure the
     amount of impairment loss.  Potential  impairment of goodwill after July 1,
     2002 is being  evaluated in accordance  with SFAS No. 142. The SFAS No. 142
     is applicable to the financial  statements of the Company beginning July 1,
     2002.

     Unearned revenue

     Unearned revenue  represents  amounts  received from the customers  against
     future sales of goods since the Company  recognizes revenue on the shipment
     of goods (see revenue recognition policy).

     Fair value of financial instruments

     Statement of financial  accounting standard No. 107, Disclosures about fair
     value  of  financial  instruments,   requires  that  the  Company  disclose
     estimated  fair  values of  financial  instruments.  The  carrying  amounts
     reported in the  statements  of financial  position for current  assets and
     current  liabilities  qualifying as financial  instruments are a reasonable
     estimate of fair value.

     Revenue Recognition


     The Company's  revenue  recognition  policies are in compliance  with Staff
     accounting  bulletin  (SAB) 101. Sales revenue is recognized at the date of
     shipment to customers when a formal arrangement  exists, the price is fixed
     or  determinable,   the  delivery  is  completed,   no  other   significant
     obligations of the Company exist and collectibility is reasonably  assured.
     Payments   received  before  all  of  the  relevant  criteria  for  revenue
     recognition are satisfied are recorded as unearned revenue.

     Advertising Costs

     The  Company   expenses  the  cost  of   advertising  as  incurred  or,  as
     appropriate,  the first time the advertising takes place. Advertising costs
     for the years ended December 31, 2003 and 2002 were insignificant.

     Stock-based compensation

     In October 1995, the FASB issued SFAS No. 123,  "Accounting for Stock-Based
     Compensation".  SFAS No. 123 prescribes  accounting and reporting standards
     for all stock-based  compensation plans,  including employee stock options,
     restricted  stock,  employee stock  purchase  plans and stock  appreciation
     rights. SFAS No. 123 requires compensation expense to be recorded (i) using
     the new fair  value  method or (ii)  using the  existing  accounting  rules
     prescribed by Accounting  Principles Board Opinion No. 25,  "Accounting for
     stock  issued  to  employees"  (APB 25) and  related  interpretations  with
     proforma  disclosure  of what net income and  earnings per share would have
     been had the Company  adopted the new fair value  method.  The Company uses
     the  intrinsic  value  method  prescribed  by APB 25 and has  opted for the
     disclosure  provisions  of SFAS No.123.  Through  December  31,  2003,  the
     Company has not granted any stock options.

                                       16

     Income Taxes

     The Company  utilizes SFAS No. 109,  "Accounting  for Income  Taxes," which
     requires the  recognition  of deferred tax assets and  liabilities  for the
     expected  future tax  consequences of events that have been included in the
     financial  statements or tax returns.  Under this method,  deferred  income
     taxes  are  recognized  for  the  tax   consequences  in  future  years  of
     differences  between  the tax bases of  assets  and  liabilities  and their
     financial  reporting  amounts at each  period end based on enacted tax laws
     and statutory tax rates  applicable to the periods in which the differences
     are  expected  to  affect   taxable   income.   Valuation   allowances  are
     established,  when  necessary,  to reduce deferred tax assets to the amount
     expected to be realized.

     According to the Provisional  Regulations of the People's Republic of China
     on Income Tax, the Document of Reductions  and Exemptions of Income Tax for
     BBST  has  been  approved  by the  local  tax  bureau  and  the  Management
     Regulation of Yang Ling  Agricultural  High-Tech  Industries  Demonstration
     Zone.  BBST  is  exempted  from  income  tax  in its  first  two  years  of
     operations.

     Foreign currency transactions and comprehensive income (loss)

     Accounting principles generally require that recognized revenue,  expenses,
     gains and losses be included in net income.  Certain  statements,  however,
     require entities to report specific changes in assets and liabilities, such
     as gain or loss on foreign currency translation, as a separate component of
     the equity section of the balance sheet. Such items, along with net income,
     are components of comprehensive  income. The functional currency of BBST is
     Chinese Renminbi.  The unit of Renminbi is in Yuan. Cumulative  translation
     adjustment amount and translation adjustment gain were insignificant at and
     for the year ended December 31, 2003 and 2002.

     Basic and diluted net loss per share

     Net loss per  share is  calculated  in  accordance  with the  Statement  of
     financial  accounting  standards  No.  128 (SFAS No.  128),  "Earnings  per
     share". SFAS No. 128 superseded  Accounting  Principles Board Opinion No.15
     (APB 15). Net loss per share for all periods presented has been restated to
     reflect the  adoption  of SFAS No.  128.  Basic net loss per share is based
     upon the weighted average number of common shares outstanding.  Diluted net
     loss per share is based on the  assumption  that all  dilutive  convertible
     shares and stock options were converted or exercised.  Dilution is computed
     by applying  the treasury  stock  method.  Under this  method,  options and
     warrants are assumed to be exercised at the  beginning of the period (or at
     the time of issuance, if later), and as if funds obtained thereby were used
     to purchase common stock at the average market price during the period.

     Statement of Cash Flows:

     In  accordance  with  Statement of Financial  Accounting  Standards No. 95,
     "Statement  of Cash Flows,"  cash flows from the  Company's  operations  is
     calculated based upon the local currencies. As a result, amounts related to
     assets and  liabilities  reported on the  statement  of cash flows will not
     necessarily agree with changes in the corresponding balances on the balance
     sheet.

     Segment Reporting

     Statement  of  Financial   Accounting   Standards  No.  131  ("SFAS  131"),
     "Disclosure  About  Segments  of an  Enterprise  and  Related  Information"
     requires use of the "management approach" model for segment reporting.  The
     management  approach  model  is  based  on the way a  company's  management
     organizes  segments within the company for making  operating  decisions and
     assessing  performance.  Reportable  segments  are  based on  products  and
     services,  geography,  legal structure,  management structure, or any other
     manner in which management  disaggregates a company. SFAS 131 has no effect
     on the Company's  consolidated financial statements as substantially all of
     the Company's operations are conducted in one industry segment.

                                       17

     Recent Pronouncements

     In May 2002, the Board issued SFAS No. 145,  Rescission of FASB  Statements
     No. 4, 44, and 64,  Amendment  of FASB  Statement  No.  13,  and  Technical
     Corrections  ("SFAS  145").  SFAS 145 rescinds the  automatic  treatment of
     gains or losses from  extinguishments of debt as extraordinary  unless they
     meet the  criteria for  extraordinary  items as outlined in APB Opinion No.
     30, Reporting the Results of Operations,  Reporting the Effects of Disposal
     of a Segment of a Business,  and  Extraordinary,  Unusual and  Infrequently
     Occurring Events and  Transactions.  SFAS 145 also requires  sale-leaseback
     accounting for certain lease  modifications that have economic effects that
     are similar to  sale-leaseback  transactions  and makes  various  technical
     corrections to existing pronouncements.  The provisions of SFAS 145 related
     to the  rescission  of FASB  Statement  4 are  effective  for fiscal  years
     beginning  after May 15, 2002,  with early adoption  encouraged.  All other
     provisions of SFAS 145 are effective for  transactions  occurring after May
     15, 2002, with early adoption encouraged.  The adoption of SFAS 145 did not
     have a  material  effect  on the  earnings  or  financial  position  of the
     Company.

     In June 2002, the FASB issued SFAS No. 146 "Accounting for Costs Associated
     with exit or  Disposal  Activities."  This  Statement  addresses  financial
     accounting  and  reporting  for  costs  associated  with  exit or  disposal
     activities and nullifies  Emerging Issues Task Force (EITF) Issue No. 94-3,
     "Liability  Recognition for Certain Employee Termination Benefits and Other
     Costs  to  Exit  an  Activity   (including  Certain  Costs  Incurred  in  a
     Restructuring)."  This  Statement  requires  that  a  liability  for a cost
     associated  with  an exit or  disposal  activity  be  recognized  when  the
     liability  is  incurred.  Under Issue 94-3 a liability  for an exit cost as
     defined,  was  recognized at the date of an entity's  commitment to an exit
     plan.  The  adoption  of SFAS 146 did not  have a  material  effect  on the
     earnings or financial position of the Company.

     In October  2002,  the FASB issued SFAS No. 147,  "Acquisitions  of Certain
     Financial  Institutions."  SFAS No. 147 removes the requirement in SFAS No.
     72 and  Interpretation  9 thereto,  to recognize and amortize any excess of
     the fair value of  liabilities  assumed over the fair value of tangible and
     identifiable  intangible  assets acquired as an  unidentifiable  intangible
     asset. This statement  requires that those transactions be accounted for in
     accordance with SFAS No. 141,  "Business  Combinations,"  and SFAS No. 142,
     "Goodwill and Other Intangible Assets." In addition,  this statement amends
     SFAS No. 144,  "Accounting  for the  Impairment  or Disposal of  Long-Lived
     Assets,"  to  include  certain  financial  institution-related   intangible
     assets.  The  adoption  of SFAS 147 did not have a  material  effect on the
     earnings or financial position of the Company.

     In November 2002, the FASB issued FASB  Interpretation No. 45, "Guarantor's
     Accounting and Disclosure  Requirements for Guarantees,  Including Indirect
     Guarantees of  Indebtedness  of Others" (FIN 45). FIN 45 requires that upon
     issuance of a guarantee,  a guarantor  must  recognize a liability  for the
     fair value of an obligation assumed under a guarantee. FIN 45 also requires
     additional  disclosures by a guarantor in its interim and annual  financial
     statements  about the obligations  associated with guarantees  issued.  The
     recognition provisions of FIN 45 are effective for any guarantees issued or
     modified after December 31, 2002. The disclosure requirements are effective
     for financial statements of interim or annual periods ending after December
     15, 2002. The adoption of this pronouncement did not have a material effect
     on the earnings or financial position of the Company.

     In December 2002, the FASB issued SFAS No. 148  "Accounting for Stock Based
     Compensation-Transition and Disclosure".  SFAS No. 148 amends SFAS No. 123,
     "Accounting for Stock Based  Compensation",  to provide alternative methods
     of  transition  for a voluntary  change to the fair value  based  method of
     accounting  for  stock-based  employee  compensation.   In  addition,  this
     Statement  amends the disclosure  requirements  of Statement 123 to require
     prominent disclosures in both annual and interim financial statements about
     the method of accounting  for  stock-based  employee  compensation  and the
     effect of the method used, on reported results.  The Statement is effective
     for the Companies'  interim  reporting  period ending January 31, 2003. The
     Company  does not expect the adoption of SFAS No. 148 would have a material
     impact on its financial position or results of operations or cash flows.

                                       18

     On April 30, 2003,  the FASB issued FASB  Statement  No. 149 ("SFAS  149"),
     "Amendment  of  Statement  133  on  Derivative   Instruments   and  Hedging
     Activities".  FAS 149 amends and clarifies the  accounting  guidance on (1)
     derivative  instruments  (including certain derivative instruments embedded
     in other  contracts) and (2) hedging  activities that fall within the scope
     of  FASB  Statement  No.  133  ("SFAS  133"),   Accounting  for  Derivative
     Instruments  and Hedging  Activities.  SFAS 149 also amends  certain  other
     existing pronouncements,  which will result in more consistent reporting of
     contracts that are  derivatives in their entirety or that contain  embedded
     derivatives that warrant separate accounting. SFAS 149 is effective (1) for
     contracts  entered  into or  modified  after June 30,  2003,  with  certain
     exceptions,  and (2) for hedging  relationships  designated  after June 30,
     2003.  The  guidance is to be applied  prospectively.  The Company does not
     expect  the  adoption  of SFAS No.  149 to have a  material  impact  on its
     financial position or results of operations or cash flows.

     On May 15 2003,  the FASB  issued  FASB  Statement  No. 150  ("SFAS  150"),
     Accounting for Certain Financial  Instruments with  Characteristics of both
     Liabilities  and  Equity.  SFAS 150  changes  the  accounting  for  certain
     financial instruments that, under previous guidance, could be classified as
     equity or  "mezzanine"  equity,  by now requiring  those  instruments to be
     classified  as  liabilities  (or  assets  in  some  circumstances)  in  the
     statement  of financial  position.  Further,  SFAS 150 requires  disclosure
     regarding the terms of those instruments and settlement alternatives.  SFAS
     150  affects  an  entity's  classification  of the  following  freestanding
     instruments: a) Mandatorily redeemable instruments b) Financial instruments
     to repurchase an entity's own equity  instruments c) Financial  instruments
     embodying  obligations  that the issuer  must or could  choose to settle by
     issuing a variable number of its shares or other equity  instruments  based
     solely on (i) a fixed monetary  amount known at inception or (ii) something
     other than changes in its own equity instruments d) SFAS 150 does not apply
     to features embedded in a financial  instrument that is not a derivative in
     its  entirety.  The  guidance in SFAS 150 is  generally  effective  for all
     financial  instruments  entered into or modified after May 31, 2003, and is
     otherwise  effective at the beginning of the first interim period beginning
     after  June  15,  2003.  For  private  companies,   mandatorily  redeemable
     financial  instruments  are subject to the  provisions  of SFAS 150 for the
     fiscal  period  beginning  after  December 15,  2003.  The Company does not
     expect  the  adoption  of SFAS No.  150 to have a  material  impact  on its
     financial position or results of operations or cash flows.

     3.   INVENTORIES

     Inventories at December 31, 2003 and 2002 were as follows:


                                                                   2003               2002
                                                                   -----              -----
                                                                           
                  Raw and packing materials                   $    450,967  $        269,353
                  Finished goods                                   429,487           678,742
                                                                   880,454           948,095
                  Less allowance for obsolescence                 (164,722)         (150,825)

                                                              --------------     -------------
                  Total                                       $    715,732  $        797,270
                                                              ==============     =============


                                       19

     4.   PROPERTY AND EQUIPMENT

     Net property and equipment at December 31, 2003 and 2002 were as follows:



                                                                      2003               2002
                                                                      ----               ----



                                                                                   
                  Building                                    $         946,888  $        942,480
                  Machinery                                             328,280           233,000
                  Furniture and office equipment                         21,265            16,828
                  Vehicles                                              147,651           118,122
                                                                      1,444,084         1,310,430
                  Less Accumulated depreciation                       (223,497)          (84,940)
                                                                  --------------     -------------
                                                              $       1,220,587  $      1,225,490
                                                                  ==============     =============

     Depreciation expense for the years ended December 31, 2003 and December 31,
     2002 was $ 138,557 and $50,000.

     The Company depreciated its production related assets at a rate double than
     the  straight  line  rate due to its  excessive  usage  in the  year  ended
     December  31,  2003.  This  factor  contributed  towards  the  increase  in
     depreciation by $61,919. The change in estimate resulted in decrease in net
     income by $61,919 or $41.27 per share for the year ended December 31, 2003.

     5. INTANGIBLE ASSETS

     Net intangible assets at December 31, 2003 and 2002 were as follows:


                                                                       2003              2002
                                                                       ----              ----

                                                                                  
                  Rights to use land                          $        1,655,248  $       184,941
                  Fertilizers proprietary technology rights              960,000          960,000
                                                                  ---------------     ------------
                                                                       2,615,248        1,144,941
                  Less Accumulated amortization                        (305,100)        (195,699)
                                                                  ---------------     ------------
                                                              $        2,310,148  $       949,242
                                                                  ===============     ============

     The  Company's  office  and  manufacturing  site is  located  in Yang  Ling
     Agricultural  High-Tech  Industries  Demonstration  Zone in the province of
     Shanxi,  People's  Republic of China.  The  Company  leases land per a real
     estate  contract with the  government  of People's  Republic of China for a
     period from November 2001 through November 2051. Per the People's  Republic
     of China's governmental regulations, the Government owns all land.

     During July 2003,  the  Company  leased  another  parcel of land per a real
     estate contract with the government of the People's Republic of China for a
     period from July 2003 through June 2053.

     The Company has recognized  the amounts paid for the  acquisition of rights
     to use land as  intangible  asset  and  amortizing  over a period  of fifty
     years. The amortization  expense of "Rights to use land" for the year ended
     December 31, 2003 and 2002 amounted to $13,401 and $3,699 respectively. The
     accumulated amortization as at December 31, 2003 was $17,100.

                                       20

     The Company acquired Fluid and Compound Fertilizers  proprietary technology
     rights with a life ending  December  31,  2011.  The Company is  amortizing
     Fertilizers  proprietary  technology rights over a period of ten years. The
     amortization expense of "Fertilizers proprietary technology rights" for the
     years ended December 31, 2003 and 2002 amounted to $96,000 and $96,000. The
     Accumulated  amortization  as on  December  31,  2003 and 2002  amounted to
     $288,000 and $192,000.

     Amortization  expense  for the  Company's  current  amortizable  intangible
     assets over the next five fiscal years is  estimated to be:  2004-$130,000,
     2005-$130,000, 2006-$130,000, 2007-$130,000 and 2008-$130,000.

     6. DIVIDEND PAYABLE

     The Shareholders of the company in their meeting dated May 9, 2003 approved
     a dividend of $180,000 for the year ended December 31, 2002.

     7. SHORT TERM LOAN

     Short term loans consisted of the following at December 31, 2003 and 2002:


                                                                                       2003             2002
                                                                                       ----             ----

                                                                                                    
                  Note payable to bank,  interest rate;  6.84% per annum,       $    480,000      $          -
                  payable quarterly,  original note;  $480,000,  maturity
                  date; 1/27/04, secured by assets of the Company.

                  Note payable to bank,  interest rate;  6.84% per annum,            600,000                 -
                  payable quarterly,  original note;  $600,000,  maturity
                  date; 9/28/04, secured by assets of the Company.

                  Short  term  support  loan from the  Shanxi  Technology             12,000            12,000
                  Bureau  of  the  Government  of  People's  Republic  of
                  China, interest free; secured by assets of the Company
                                                                               --------------     -------------
                                                                                $  1,092,000      $     12.000
                                                                               ==============     =============

     8. SHAREHOLDERS' EQUITY

     On December  15, 2003,  the Company  entered in to an agreement to exchange
     1500 shares of its common stock for all the issued and outstanding stock of
     BBST. After the consummation of the agreement,  the former  shareholders of
     BBST own 1500 shares of common stock of the Company,  which  represent 100%
     of the Company's issued and outstanding shares.

     From its inception  through its  acquisition on December 15, 2003 (see note
     1), BBST had issued  49,200,000  shares of its common stock for  $6,014,400
     including issuance of 9,200,000 shares to various parties for $1,214,400 in
     the year ended December 31, 2003.

                                       21

     9. RELATED PARTY TRANSACTIONS

     A loan of $217,338 from various  shareholders of the Company outstanding as
     at December  31, 2001 was fully repaid  during the year ended  December 31,
     2002 along with an interest expense of $ 20,249.

     10. SUPPLEMENTAL DISCLOSURE OF CASH FLOWS

     The Company prepares its statements of cash flows using the indirect method
     as defined under the Financial Accounting Standard No. 95.

     The Company  paid  interest of $ 41,359 and $ 20,249  during the year ended
     December  31, 2003 and 2002.  The Company did not pay income tax during the
     years ended December 31, 2003 and 2002.

     11. EMPLOYEE WELFARE PLAN

     The Company has  established  its own employee  welfare plan in  accordance
     with  Chinese  law  and  regulations.  The  Company  makes  annual  pre-tax
     contributions of 14% of all employees' salaries.  The total expense for the
     above plan amounted to $55,813 and $21,000 for the years ended December 31,
     2003 and 2002.

     12. STATUTORY RESERVE

     In accordance  with the Chinese  Company Law, the company has allocated 10%
     of its annual net income,  amounting  $197,036  and  $66,758,  as statutory
     reserve on December 31, 2003 and 2002.

                                       22

Exhibit 2
                               STRATABID.COM, INC.
                        PRO FORMA STATEMENT OF OPERATIONS
                      FOR THE YEAR ENDED DECEMBER 31, 2003
                                   (Unaudited)

The following Unaudited Pro Forma Statement of operations has been derived from
the audited financial statements of Stratabid.com, Inc., a Delaware Corporation
(A) for the year ended December 31, 2003 and the audited financial statements of
Bodisen International, Inc., a Delaware Corporation (B) for the year ended
December 31, 2003. The Pro Forma Statements of Operations reflects the
acquisition of B by a wholly-owned subsidiary of the Company A (a reporting
company) on February 24, 2004 in a acquisition using reverse acquisition method
of accounting and assumes that such acquisition was consummated as of January 1,
2003.

The Pro Forma Statement of Operations and financial conditions should be read in
conjunction with the Financial Statements of A, the Financial Statements of B
and the Notes to the financial statements. The Pro Forma Statements do not
purport to represent what the Company's results of operations and financial
conditions would actually have been if the acquisition of A had occurred on the
d accompanying data, are based on available information and the assumption set
forth in the foot notes below, which management believes are reasonable.



                                                                      A              B            Pro Forma          Pro Forma
                                                                (Historical)    (Historical)      Adjustment         Combined
                                                                --------------  -------------   ---------------   ----------------
                                                                                                      
Net Revenue                                                     $      58,256   $  9,783,784    $     -           $     9,842,040

Cost of revenue                                                             -      6,706,082          -                 6,706,082
                                                                --------------  -------------   ----------------  ----------------

Gross profit                                                           58,256      3,077,702          -                 3,135,958

Operating expenses                                                    107,592      1,204,208          -                 1,311,800
                                                                --------------  -------------   ----------------  ----------------

Loss from operations                                                  (49,336)     1,873,494          -                 1,824,158

Non-operating income (Expenses)                                             -         96,867          -                    96,867
                                                                --------------  -------------   ----------------  ----------------

Net gain/loss                                                   $     (49,336)  $  1,970,361    $     -           $     1,921,025
                                                                ==============  =============   ===============   ================

EARNINGS PER SHARE

   Weighted -average number of
   shares outstanding                                               1,567,000      3,000,000                            4,567,000
                                                                ==============  =============                     ================

   Gain/loss per share                                          $       (0.03)  $       0.66                      $          0.42
                                                                ==============  =============                     ================

NOTES:

(1)  Loss per share data shown above are applicable for both primary and fully
     diluted.

(2)  Weighted-average number of shares outstanding for the combined entity
     includes all shares issued before the acquisition as if outstanding as of
     January 1, 2003.

(3)  Weighted average number of shares outstanding for combined entity includes
     1,567,000 shares of A outstanding shares as of December 31, 2003 and
     3,000,000 shares of common stock issued to the shareholders of (B) pursuant
     to the stock acquisition and reorganization agreement.

                                       23

                               STRATABID.COM, INC.
                   PRO FORMA STATEMENT OF FINANCIAL CONDITIONS
                     FOR THE PERIOD ENDED DECEMBER 31, 2003
                                   (Unaudited)

The following unaudited Pro Forma Statement of financial conditions has been
derived from the audited financial statements of Stratabid.com, Inc. (A) as of
December 31, 2002 and the audited financial statements of Bodisen International,
Inc. (B) as of December 31, 2003. The unaudited Pro Forma Statements of
financial conditions reflects the acquisition of B by a wholly-owned subsidiary
of A (a reporting company) in a merger using reverse acquisition method of
accounting.


                                                            A              B                               Pro Forma      Pro Forma
                                                      (Historical)    (Historical)      Investment        Adjustment      Combined
                                                     --------------  -------------   ---------------   ---------------  -----------
                           ASSETS

                                                                                                           
Current Assets                                       $      14,627   $  7,446,862    $          -      $          -       7,461,489

Property & equipment, net                                    4,058      1,220,587               -                 -       1,224,645

Intangible assets, net                                    1,375.00      2,310,148               -                 -       2,311,523

Capital work in progress                                         -        222,083               -                 -         222,083

Investment - acquisition of subsidiary                           -              -       4,500,000(2)     (4,500,000)(4)           -

                                                     --------------  -------------   ---------------   ---------------- ------------
TOTAL ASSETS                                         $      20,060   $ 11,199,680    $  4,500,000      $ (4,500,000)    $11,219,740
                                                     ==============  =============   ===============   ================ ============
LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities                                  $      21,050   $  2,832,106    $          -      $          -       2,853,156

Stockholders' equity;

  Common stock                                                 157              1             300(2)             (1)(1)         457


  Additional paid in capital                               113,211      6,014,399       4,499,700(2)     (4,644,357)(4)   5,982,953

  Statutory reserve                                              -        263,795               -                 -         263,795

  Donated Capital                                           30,000              -               -                 -          30,000

  Accumulated other comprehensive gain (loss)                  818              -               -              (818)(3)           -

  Retained earnings (deficit)                             (145,176)     2,089,379               -           145,176 (3)   2,089,379
                                                     --------------  -------------   ---------------   ---------------- ------------

     Total stockholders' equity (deficit)                     (990)     8,367,574       4,500,000        (4,500,000)      8,366,584
                                                     --------------  -------------   ---------------   ---------------- ------------

TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY (DEFICIT)                                     $      20,060 $   11,199,680    $  4,500,000      $ (4,500,000)    $11,219,740
                                                     ==============  =============   ===============   ================ ============


NOTES;

(1) Elimination of Common stock of (B) before the acquisition

(2) Issuance of shares of common stock to shareholder of (B) valued at
$4,500,000

(3) Elimination of pre-acquisition retained earnings of (B)

(4) Elimination of investment in subsidiary on consolidation

                                       24